Nom du produit:3-Fluoro-4-(4-formylphenoxy)benzonitrile
IUPAC Name:3-fluoro-4-(4-formylphenoxy)benzonitrile
- CAS:676494-55-6
- Formule moléculaire:C14H8FNO2
- Pureté:96%
- Numéro de catalogue:CM243364
- Poids moléculaire:241.22
Unité d'emballage |
Stock disponible |
Prix($) |
Quantité |
CM243364-1g |
3-4 Weeks |
-- |
|
|
|
Pour une utilisation en R&D uniquement..
Détails du produit
- N° CAS:676494-55-6
- Formule moléculaire:C14H8FNO2
- Point de fusion:-
- Code SMILES:N#CC1=CC=C(OC2=CC=C(C=O)C=C2)C(F)=C1
- Densité:
- Numéro de catalogue:CM243364
- Poids moléculaire:241.22
- Point d'ébullition:
- N° Mdl:
- Stockage:
Column Infos
- Aticaprant
- Major depressive disorder is a leading cause of disability worldwide. Kappa opioid receptors (KORs) are a promising new therapeutic target for major depressive disorder and anhedonia. Aticaprant is a KOR antagonist developed by Johnson & Johnson’s Janssen. Aticaprant is currently being tested as an adjunctive therapy to a current antidepressant in MDD patients with a focus on treating anhedonia. Studies are expected to be completed in mid-to-late 2024 and 2025.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.